GAVISCON EXTRA STRENGTH peppermint oral liquid bottle

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

sodium alginate, Quantity: 100 mg/mL; potassium bicarbonate, Quantity: 20 mg/mL; calcium carbonate, Quantity: 20 mg/mL

Available from:

Reckitt Benckiser Pty Ltd

Pharmaceutical form:

Oral Liquid, suspension

Composition:

Excipient Ingredients: propyl hydroxybenzoate; saccharin sodium; methyl hydroxybenzoate; purified water; carbomer 934P; sodium hydroxide; Flavour

Administration route:

Oral

Units in package:

300mL, 140mL, 500mL, 250mL

Prescription type:

Not scheduled. Not considered by committee

Therapeutic indications:

For the relief of the symptoms associated with reflux oesophagitis, hiatus hernia and all cases of epigastric distress where the underlying cause is gastro-oesophageal reflux.

Product summary:

Visual Identification: Off-white suspension; Container Type: Bottle; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Registered

Authorization date:

2020-10-21